Alpha DNA Investment Management’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,025
Closed -$797K 216
2024
Q1
$797K Buy
+7,025
New +$722K 0.29% 72
2023
Q3
Sell
-11,949
Closed -$1.08M 184
2023
Q2
$1.08M Buy
+11,949
New +$1.01M 0.36% 56
2021
Q4
Sell
-17,756
Closed -$1.67M 119
2021
Q3
$1.67M Sell
17,756
-1,755
-9% -$175K 1.14% 14
2021
Q2
$1.88M Buy
19,511
+8,562
+78% +$805K 1.28% 6
2021
Q1
$987K Sell
10,949
-2,295
-17% -$197K 1.13% 9
2020
Q4
$1.06M Buy
+13,244
New +$985K 1.13% 9

Other funds holding EMR

Alpha DNA Investment Management's EMR Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Emerson Electric (EMR) in Q2 2024, closing a stake of 7,025 shares — an estimated $797K sold.

Alpha DNA Investment Management first reported a position in EMR in Q4 2020 and held it in 6 quarters. The position peaked at $1.88M in Q2 2021. 1,950 funds tracked by Wall St. Rank hold EMR as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Emerson Electric position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,025 Emerson Electric shares in Q2 2024, an estimated $797K.
  • Alpha DNA Investment Management first reported a position in Emerson Electric in Q4 2020 and held it in 6 quarters.
  • Alpha DNA Investment Management's Emerson Electric position peaked at $1.88M in Q2 2021.
  • 1,950 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.